Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/165093
Title: Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016.
Author: Martínez-Gómez, Xavier
Curran, Adrian
Campins, Magda
Alemany i Vilches, Laia
Rodrigo-Pendás, José Ángel
Borruel, Natalia
Castellsagué, Xavier
Díaz-de-Heredia, Cristina
Moraga Llop, Fernando A.
Pino Saladrigues, Marta del
Torné Bladé, Aureli
Keywords: Vacuna del papil·lomavirus
Immunogenètica
Papillomavirus vaccines
Immunogenetics
Issue Date: 24-Feb-2019
Publisher: European Centre for Disease Prevention and Control (ECDC)
Abstract: Introduction: Although human papillomavirus (HPV) routine vaccination programmes have been implemented around the world and recommendations have been expanded to include other high-risk individuals, current recommendations often differ between countries in Europe, as well as worldwide. Aim: To find and summarise the best available evidence of HPV vaccination in high-risk patients aiding clinicians and public health workers in the day-to-day vaccine decisions relating to HPV in Spain. Methods: We conducted a systematic review of the immunogenicity, safety and efficacy/effectiveness of HPV vaccination in high-risk populations between January 2006 and June 2016. HPV vaccination recommendations were established with levels of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Results: A strong recommendation about HPV vaccination was made in the following groups: HIV infected patients aged 9-26 years; men who have sex with men aged 9-26 years; women with precancerous cervical lesions; patients with congenital bone marrow failure syndrome; women who have received a solid organ transplant or hematopoietic stem cell transplantation aged 9-26 years; and patients diagnosed with recurrent respiratory papillomatosis. Conclusions: Data concerning non-routine HPV vaccination in populations with a high risk of HPV infection and associated lesions were scarce. We have developed a document to evaluate and establish evidence-based guidelines on HPV vaccination in high-risk populations in Spain, based on best available scientific evidence.
Note: Reproducció del document publicat a: https://doi.org/10.2807/1560-7917.ES.2019.24.7.1700857
It is part of: Eurosurveillance, 2019, vol. 24, num. 7, p. 1700857
URI: http://hdl.handle.net/2445/165093
Related resource: https://doi.org/10.2807/1560-7917.ES.2019.24.7.1700857
ISSN: 1025-496X
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
695643.pdf264.72 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons